Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature by Belal Firwana, Bassel Atassi, Rim Hasan, Nour Hasan, Ammar Sukari

Get full text

Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report by Abdurahman Alloghbi, James Ninia, Bayan Alshare, Jeffrey Hotaling, Syed Raza, Ammar Sukari

Get full text

Femoral metastasis in previously treated bladder cancer patient: A case report by Tala Jouma Alhejazi, Hassan Bdeiwi, Mohamad W. Sukkari, Mohamad Ibrahim, Ammar Sukari, Hani Alloush

Get full text

Cancer Care at Times of Crisis and War: The Syrian Example by Eman Sahloul, Riad Salem, Wessam Alrez, Tayseer Alkarim, Ammar Sukari, Wasim Maziak, M. Bassel Atassi

Get full text

NTRK3 mutation in secretory carcinoma of the parotid gland: A Case report by Fahad AlKaabba, Abdurahman Alloghbi, Yazeed Deajim, Mohamad W. Sukkari, Mir Yousufuddin Ali Khan, Ammar Sukari

Get full text

Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer by Misako Nagasaka, Mohammed Hafiz Uddin, Mohammed Najeeb Al-Hallak, Sarah Rahman, Suresh Balasubramanian, Ammar Sukari, Asfar S. Azmi

Get full text

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck by Ammar Sukari, Marwan Al-Hajeili, Mohamed Salem, Lance Heilbrun, Daryn Smith, George Yoo, John R Jacobs, Ho-Sheng Lin, Omer Kucuk

Get full text

STRN-ALK, A Novel In-Frame Fusion With Response to Alectinib by Misako Nagasaka, MD, Nagaratna Sarvadevabatla, MD, Shawn Iwata, BSN, Yubin Ge, PhD, Ammar Sukari, MD, Christian Klosowski, MS, Ronald Yanagihara, MD

Get full text

Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study. by Zeenat Yousuf Bhat, Pravit Cadnapaphornchai, Kevin Ginsburg, Milani Sivagnanam, Shamit Chopra, Corey K Treadway, Ho-Sheng Lin, George Yoo, Ammar Sukari, Mona D Doshi

Get full text

390 Emerging safety and activity data from GEN-009–101: A phase 1/2a trial of GEN-009, a neoantigen vaccine in combination with PD-1 check-point inhibitors (CPI) in advanced solid... by Thomas Davis, Jessica Price, Ammar Sukari, Roger Cohen, Przemyslaw Twardowski, Jessica Flechtner, Melissa Johnson, Maura Gillison, Rudy Lackner, Arthur DeCillis, Richard Hernandez, Kevin Mancini, Mara Shainheit

Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes by Hira Shaikh, Julie E. McGrath, Brittany Hughes, Joanne Xiu, Pavel Brodskiy, Ammar Sukari, Sourat Darabi, Chukwuemeka Ikpeazu, Chadi Nabhan, Wolfgang Michael Korn, Trisha M. Wise-Draper

Get full text

957 NKTR-255+cetuximab in patients with solid tumors: interim safety and efficacy results from the phase 1b dose-escalation study by Manish Patel, Amita Patnaik, Ammar Sukari, Minal Barve, Mary Tagliaferri, Neha Dixit, Mehmet Altan, Christie Fanton, Xiaoli Wang, Sunil Sharma, Mario Marcondes, Sue Currie, Zachary Lee, Wildaliz Nieves, Haijun Ma, Lara Dunn, Patrick Cobb, Ari Rosenberg, Johnathan Zalevsky, Assuntina Sacco

485 Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors by Thomas Davis, Jessica Price, Mark Awad, Ammar Sukari, Roger Cohen, Mark Stein, Przemyslaw Twardowski, Jessica Flechtner, Melissa Johnson, Maura Gillison, Rudy Lackner, Arthur DeCillis, Richard Hernandez, Kevin Mancini, Mara Shainheit, Gabriella Santone, Syukri Shukor, Ece Bicak, Vijetha Vemulapalli, Emily Tjon

438 A phase 1 trial of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck... by Michael Gibson, Ammar Sukari, Julie Bauman, Tanguy Seiwert, Barbara Burtness, Sara Pai, Cristina Rodriguez, Bonnie Glisson, Kenneth Pienta, Francis Worden, Lara Dunn, Douglas Adkins, Christine Chung, A Dimitrios Colevas, Lori Wirth, Nabil Saba, Laura Agensky, Matteo Levisetti, Reena Lynam, Steven Margossian, Raymond Moniz, Steve Quayle

Biomarkers predictive of response to pembrolizumab in head and neck cancer by David G. Pfister, Robert I. Haddad, Francis P. Worden, Jared Weiss, Ranee Mehra, Laura Q. M. Chow, Stephen V. Liu, Hyunseok Kang, Nabil F. Saba, Lori J. Wirth, Ammar Sukari, Erminia Massarelli, Mark Ayers, Andrew Albright, Andrea L. Webber, Robin Mogg, Jared Lunceford, Lingkang Huang, Razvan Cristescu, Jonathan Cheng, Tanguy Y. Seiwert, Joshua M. Bauml

Get full text

674 A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy in 3L and in combination with pembrolizumab in 1L recurrent/metastatic HPV16+ head and neck cance... by Faye Johnson, Nashat Gabrail, Ammar Sukari, Barbara Burtness, Christine H Chung, Sara Pai, Lara A Dunn, Cristina Rodriguez, Marya Chaney, Apollina Goel, Ricklie Julian, Francis Worden, Rami Haddad, Douglas Adkins, A Dimitrios Colevas, Laura Agensky, Matteo Levisetti, Steven Margossian, Steve Quayle, Jong Chul Park, Robert M Jotte, Tanguy Y Seiwert, Nabil F Saba, Julie E Bauman, Michael K Gibson